A human CD4- CD8- T-cell receptor alpha beta + T leukemic cell line undergoing phytohemagglutinin-induced apoptosis. 1995

M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
Department of Pediatric Oncology, Tohoku University, Sendai, Japan.

A human CD4- CD8- alpha beta T-cell receptor (TCR alpha beta)+ T leukemic cell line, L-KAW, was established from the peripheral blood of a 6-year-old male patient with T-cell acute lymphoblastic leukemia. Its phenotype was found to be CD7+CD2+CD3+CD4-CD8- TCR alpha beta +. The cell line proved susceptible to killing by exposure to a mitogenic concentration of phytohemagglutinin (PHA) within several hours, with biochemical analyses demonstrating extensive degradation of DNA to oligonucleosomal bands characteristic of apoptosis. Chromatin condensation and cell shrinkage features of apoptotic cells could also be clearly identified under the electron microscope. The apoptosis-related Fas antigen was expressed on L-KAW cells and DNA fragmentation was induced by incubation with anti-Fas monoclonal antibody. The c-myc mRNA levels declined within 15 min to 3 h after the addition of PHA. These results suggest that L-KAW cells are specifically sensitive to induction of apoptosis in response to PHA without preactivation. They may, therefore, be considered an analog of activated T-cells and prove useful as a model system for characterizing biochemical and molecular mechanisms underlying the process of this type of cell death.

UI MeSH Term Description Entries
D008297 Male Males
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
April 1995, Immunology,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
March 1991, Lancet (London, England),
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
November 1991, Journal of immunology (Baltimore, Md. : 1950),
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
August 1992, Journal of immunology (Baltimore, Md. : 1950),
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
July 1989, Proceedings of the National Academy of Sciences of the United States of America,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
January 1989, International journal of cancer. Supplement = Journal international du cancer. Supplement,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
September 1991, Clinical and experimental immunology,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
May 1995, Immunology,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
January 1996, European journal of immunology,
M Minegishi, and N Minegishi, and T Yanagisawa, and S Tsuchiya, and H Tezuka, and M Kaji, and M Nakamura, and Y Hayashi, and T Konno
March 1989, European journal of immunology,
Copied contents to your clipboard!